Next Century Growth Investors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-313,724
Closed -$13.7M 118
2023
Q3
$13.7M Buy
+313,724
New +$15.3M 1.49% 21
2016
Q3
Sell
-125,959
Closed -$1.78M 181
2016
Q2
$1.78M Sell
125,959
-55,642
-31% -$848K 0.08% 157
2016
Q1
$3.06M Sell
181,601
-168,272
-48% -$2.96M 0.14% 134
2015
Q4
$7.85M Sell
349,873
-6,568
-2% -$135K 0.34% 83
2015
Q3
$7.81M Sell
356,441
-79,458
-18% -$1.99M 0.32% 81
2015
Q2
$10.7M Buy
435,899
+41,561
+11% +$928K 0.37% 82
2015
Q1
$8.08M Buy
394,338
+2,973
+0.8% +$57.6K 0.28% 104
2014
Q4
$7.81M Buy
391,365
+36,612
+10% +$628K 0.28% 98
2014
Q3
$5.22M Sell
354,753
-7,724
-2% -$123K 0.18% 131
2014
Q2
$6.66M Buy
362,477
+48,709
+16% +$811K 0.21% 126
2014
Q1
$5.9M Buy
+313,768
New +$6.43M 0.18% 140

Other funds holding ATRC

Next Century Growth Investors's ATRC Position: Q4 2023 in Review

Next Century Growth Investors sold out of AtriCure (ATRC) in Q4 2023, closing a stake of 313,724 shares — an estimated $13.7M sold.

Next Century Growth Investors first reported a position in ATRC in Q1 2014 and held it in 11 quarters. The position peaked at $13.7M in Q3 2023. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.

  • Next Century Growth Investors reported no remaining AtriCure position as of Q4 2023 after selling out during the quarter.
  • Next Century Growth Investors sold 313,724 AtriCure shares in Q4 2023, an estimated $13.7M.
  • Next Century Growth Investors first reported a position in AtriCure in Q1 2014 and held it in 11 quarters.
  • Next Century Growth Investors's AtriCure position peaked at $13.7M in Q3 2023.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.

Based on Next Century Growth Investors's 13F filing for Q4 2023, filed 14 Feb 2024.